Abstract: The present disclosure relates to a capacitive touch-type power seat switch using a receptacle, mounted on a seat of a vehicle and configured to control a position of the seat and a function thereof, the power seat switch comprising: a knob configured to be moved upwards, downwards, leftwards, and rightwards by operation of a user; an operation transmission unit configured to transmit an operation direction of the knob when the knob is moved upwards, downwards, leftwards, and rightwards, and to implement a function of the power seat switch in response to an operation signal according to the transmitted operation direction; a receptacle installed in a PCB provided in the operation transmission unit; a sensor electrode electrically connected to the receptacle and configured to detect variation in capacitance; and a sensor circuit part electrically connected to the sensor electrode.

Abstract: The present disclosure relates to a capacitive touch-type power seat switch using a receptacle, mounted on a seat of a vehicle and configured to control a position of the seat and a function thereof, the power seat switch comprising: a knob configured to be moved upwards, downwards, leftwards, and rightwards by operation of a user; an operation transmission unit configured to transmit an operation direction of the knob when the knob is moved upwards, downwards, leftwards, and rightwards, and to implement a function of the power seat switch in response to an operation signal according to the transmitted operation direction; a receptacle installed in a PCB provided in the operation transmission unit; a sensor electrode electrically connected to the receptacle and configured to detect variation in capacitance; and a sensor circuit part electrically connected to the sensor electrode.

Abstract: The present invention relates to a fluorene derivative or a pharmaceutically acceptable salt thereof, a preparation method therefor, and a pharmaceutical composition comprising the same as an effective ingredient for preventing or treating HCV-related disease. A fluorene derivative according to the present invention is identified to exhibit an antiviral performance against not only HCV, but also highly against HCV mutants, particularly double mutants and thus can be used in a pharmaceutical composition for prevention or treatment of HCV-caused liver disease, such as acute hepatitis C, chronic hepatitis C, liver cirrhosis, hepatocellular cancer, etc., particularly, liver disease caused by mutants of HCV. The derivative can be useful in a pharmaceutical composition for prevention or treatment of HCV-related liver disease by which the problem of resistant mutation against conventional therapeutic agents is solved.

Abstract: The present invention relates to a fluorene derivative or a pharmaceutically acceptable salt thereof, a preparation method therefor, and a pharmaceutical composition comprising the same as an effective ingredient for preventing or treating HCV-related disease. A fluorene derivative according to the present invention is identified to exhibit an antiviral performance against not only HCV, but also highly against HCV mutants, particularly double mutants and thus can be used in a pharmaceutical composition for prevention or treatment of HCV-caused liver disease, such as acute hepatitis C, chronic hepatitis C, liver cirrhosis, hepatocellular cancer, etc., particularly, liver disease caused by mutants of HCV. The derivative can be useful in a pharmaceutical composition for prevention or treatment of HCV-related liver disease by which the problem of resistant mutation against conventional therapeutic agents is solved.